3.8106.85% ( -0.280 )
Closed: Nov 16, 16:00:00 (EDT)Profile
About

Azora Therapeutics
AZR.US
Azora Therapeutics, Inc. operates as a biopharmaceutical company that develops small molecule new chemical entities for the treatment of autoimmune and inflammatory diseases. It offers treatment for dermatology and gastroenterology. The company's pipeline includes AT177, a colon-targeted aryl hydrocarbon receptor (AhR) agonist to enable localized activation with limited systemic exposure in development for ulcerative colitis.
Profile
- Company Name
- Azora Therapeutics, Inc.
- Market
- NasdaqCM
- Founded
- Industry
- --
- Fiscal Year End
- --
- Website
- www.azoratherapeutics.com
Related Securities
Industry
Industry RankingsValueRank
Management
NamePosition
